Diaceutics Wins at Export Industry Awards
Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export Industry Awards in Dublin. The awards, organised by the Irish Exporters Association (IEA), recognise the remarkable achievements of companies working in the export industry, including Irish exporters of manufactured goods and services, and large multinational corporations.
Diaceutics bested strong competition from a broad range of industries in its category to claim the Small & Emerging Exporter of the Year award, which recognises its exceptional performance and export strategy in relation to introducing new products and services to the precision medicine market. The judges were particularly impressed with the passion and drive of the organisation coupled with its unique vision on making the promise of precision medicine a reality.
Diaceutics helps pharmaceutical companies not only understand the diagnostic testing landscape by gathering real time data from the laboratories carrying out the tests, but it also assesses the market for each drug and maximises return on investment. In order to deliver its services globally, Diaceutics exports knowledge and data. It employs, from Ireland, a group of field experts internationally, hailing from the laboratory, diagnostic and pharmaceutical industries.
The award is testament to the company’s innovative approach and consistently strong growth rate, which has been 50% year-on-year for over the last three years, as well as its increasing international influence. This is evident from its partnerships with 29 out of the 30 top pharmaceutical companies and its activities in the top 10 pharmaceutical markets – including the US, France, Germany, the UK, Italy, Spain, Brazil, China, Russia and Australia.
It comes in the same year that Diaceutics announced a multimillion-euro partnership with a large US commercial reference laboratory and the creation of 30 jobs by the end of 2018.
Peter Keeling, Chief Executive Officer, Diaceutics, said: “While we have given more than half a million patients the best possible chance of recovery by ensuring better testing and therefore better treatment, we will continue to work to bridge the gap between doctors, laboratories and pharmaceutical companies across all areas of medicine.”
CAPTION:
Pictured (left to right) are: Nicola Byrne, President, Irish Exporters Association; Peter Keeling, Chief Executive Officer, Diaceutics; Ciaran Quilty, Vice President, Facebook.
